EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 16 May 2024

#Imagine if people living with rare diseases had a better chance to live a healthy life

Hear more from David Loew, second Vice President, EFPIA, and CEO Ipsen.

News

Joint business statement on the EU Proposal on Compulsory Licensing
13 May 2024

We believe that, in its current form, this initiative will undermine innovation and competitiveness of European companies,... Read more

Blogs

Advancing Clinical Trials for European Patients
16 May 2024 - Tom Metcalfe - Stefan Schwoch - Max Wegner

Now is the time to catalyse healthcare innovation – improving patients’ lives and restoring Europe as a powerhouse for... Read more

Patient involvement in HTA
15 May 2024

Health Technology Assessments: What can we learn from experiences across Europe? Read more

Countdown to the EU HTA: how can we seize this opportunity to improve patient access to medicines?...
04 June 2024

In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at... Read more

Join EFPIA as an Associate Director, Health Systems

Passionate about shaping European healthcare policy? EFPIA is looking for an Associate Director to join the health systems team.

Learn more about the position here.

Events

Innovative Approaches to Regulatory Reliance
23 May 2024 (Virtual event)

Global Trends and Perspectives for Latin America and the Caribbean Read more

Five ways to reduce cancer care inequalities in Europe: Looking beyond the elections.
27 May 2024 (Online event)

From May 27th to May 31st, 2024, CPE will host a series of daily 45 minute webinars addressing actionable steps to reduce... Read more

Event report "Digitally-enabled healthcare: Is our ecosystem on track?"

On 7 March 2024, the EU Health Coalition organised an event to discuss the current state of digital transformation within healthcare systems and address the fundamental challenges that hinder the acceleration of the data-driven revolution.

Read the event report and watch the recording.

What we are reading

From resistance to resilience: what could the future antibiotic pipeline look like?
On 14 May 2024 (IFPMA)

The World Health Organization (WHO) has identified antimicrobial resistance (AMR) as... Read more

Enabling, not rewarding
On 13 May 2024 (Copenhagen Economics)

How to design a high unmet medical needs category to drive, not deter, innovation in... Read more

France: Europe’s highest tax burden for pharma industry, lobby warns
On 03 May 2024 (Euractiv)

France is the European country with the highest tax burden for pharmaceutical companies,... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu